Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_assertion description "[Overexpression of high-mobility group A2 was observed in 39% (38/98) of pituitary adenomas compared with normal adenohypophysial tissue and was frequently found in adenomas including prolactin (PRL), adrenocorticotrophic hormone, or follicle-stimulating hormone/luteinizing hormone and in null cell adenomas, but relatively rare in growth hormone (GH) and mixed GH/PRL adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_assertion evidence source_evidence_literature NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_assertion SIO_000772 19136928 NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_assertion wasDerivedFrom befree-20150227 NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_assertion wasGeneratedBy ECO_0000203 NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.
- befree-20150227 importedOn "2015-02-27" NP423712.RAFbF-rksEvNUVc924sIHvc2d7gAvVwzHis8kibXH34ww130_provenance.